Ramatercept

DB15116Investigational

Ramatercept is under investigation in clinical trial NCT00952887 (A Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of ACE-031 in Healthy Postmenopausal Women).

Mechanism: Pharmacologically active on Growth/differentiation factor 8
Curator reviewed
Code names: ACE-031

Resolves to

Compound

UNII42HQC6QLEKCAS1169766-01-1

Targets

O14793MSTN

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

3Clinical trialsPhase, status and sponsor resolved per trial

5+ReferencesStructured and connected to the statements they support

Which drugs share a target with Ramatercept, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account